GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Baxter International Inc. (BAX) [hlAlert]

Rating:
Outperform
BAX
down 44.23 %

Baxter International Inc. (BAX) upgraded to Outperform by Credit Suisse

Posted on: Monday,  Nov 18, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Baxter International Inc. (NYSE: BAX) on 11/18/2013, when the stock price was $69.20. Since
then, Baxter International Inc. has lost 44.23% as of 11/16/2015's recent price of $38.59.
If you would have followed this Credit Suisse's recommendation on BAX, you would have lost 44.23% of your investment in 728 days.

Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/18/2013 8:25 AM Buy
None
69.20
as of 12/13/2013
1 Week down  -1.66 %
1 Month down  -4.23 %
3 Months down  -14.16 %
1 YTD down  -13.92 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/2/2013 8:25 AM Hold
None
64.65 73.00
7/10/2013 8:25 AM Buy
None
71.59
7/17/2009 8:25 AM Hold
None
54.72 59.00
11/7/2007 11:25 AM Hold
None
58.60 63.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy